Literature DB >> 28511595

Presence and Predictive Value of Obsessive-Compulsive Symptoms in Anxiety and Depressive Disorders.

Mieke Klein Hofmeijer-Sevink1, Neeltje M Batelaan2, Harold J G M van Megen1, Marcel A van den Hout3,4, Brenda W Penninx2, Anton J L M van Balkom2, Danielle C Cath3,4,5.   

Abstract

OBJECTIVE: Obsessive-compulsive symptoms (OCS) co-occur frequently with anxiety and depressive disorders, but the nature of their relationship and their impact on severity of anxiety and depressive disorders is poorly understood. In a large sample of patients with anxiety and depressive disorders, we assessed the frequency of OCS, defined as a Young Adult Self-Report Scale-obsessive-compulsive symptoms score >7. The associations between OCS and severity of anxiety and/or depressive disorders were examined, and it was investigated whether OCS predict onset, relapse, and persistence of anxiety and depressive disorders.
METHODS: Data were obtained from the third (at 2-year follow-up) and fourth wave (at 4-year follow-up) of data collection in the Netherlands Study of Anxiety and Depression cohort, including 469 healthy controls, 909 participants with a remitted disorder, and 747 participants with a current anxiety and/or depressive disorder.
RESULTS: OCS were present in 23.6% of the total sample, most notably in those with current combined anxiety and depressive disorders. In patients with a current disorder, OCS were associated with severity of this disorder. Moreover, OCS predicted (1) first onset of anxiety and/or depressive disorders in healthy controls (odds ratio [OR], 5.79; 95% confidence interval [CI], 1.15 to 29.14), (2) relapse in those with remitted anxiety and/or depressive disorders (OR, 2.31; 95% CI, 1.55 to 3.46), and (3) persistence in patients with the combination of current anxiety and depressive disorders (OR, 4.42; 95% CI, 2.54 to 7.70) within the 2-year follow-up period Conclusions: OCS are closely related to both the presence and severity of anxiety and depressive disorders and affect their course trajectories. Hence, OCS might be regarded as a course specifier signaling unfavorable outcomes. This specifier may be useful in clinical care to adapt and intensify treatment in individual patients.

Entities:  

Keywords:  anxiety disorders; comorbidity; course; depressive disorders; obsessive-compulsive symptoms; prevalence; prognosis; severity

Mesh:

Year:  2017        PMID: 28511595      PMCID: PMC5788131          DOI: 10.1177/0706743717711170

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  43 in total

Review 1.  The psychometric properties of the Composite International Diagnostic Interview.

Authors:  G Andrews; L Peters
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1998-02       Impact factor: 4.328

2.  Cognitive behavioral therapy for panic disorder and comorbidity: more of the same or less of more?

Authors:  Michelle G Craske; Todd J Farchione; Laura B Allen; Velma Barrios; Milena Stoyanova; Raphael Rose
Journal:  Behav Res Ther       Date:  2006-10-27

3.  Diagnostic comorbidity in panic disorder: effect on treatment outcome and course of comorbid diagnoses following treatment.

Authors:  T A Brown; M M Antony; D H Barlow
Journal:  J Consult Clin Psychol       Date:  1995-06

4.  A cognitive-behavioral group for patients with various anxiety disorders.

Authors:  David H Erickson; Amy S Janeck; Karen Tallman
Journal:  Psychiatr Serv       Date:  2007-09       Impact factor: 3.084

5.  Agoraphobia is a disease: a tribute to Sir Martin Roth.

Authors:  Giovanni A Fava; Chiara Rafanelli; Eliana Tossani; Silvana Grandi
Journal:  Psychother Psychosom       Date:  2008-02-14       Impact factor: 17.659

6.  The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods.

Authors:  Brenda W J H Penninx; Aartjan T F Beekman; Johannes H Smit; Frans G Zitman; Willem A Nolen; Philip Spinhoven; Pim Cuijpers; Peter J De Jong; Harm W J Van Marwijk; Willem J J Assendelft; Klaas Van Der Meer; Peter Verhaak; Michel Wensing; Ron De Graaf; Witte J Hoogendijk; Johan Ormel; Richard Van Dyck
Journal:  Int J Methods Psychiatr Res       Date:  2008       Impact factor: 4.035

7.  Clinical relevance of comorbidity in obsessive compulsive disorder: the Netherlands OCD Association study.

Authors:  Mieke Klein Hofmeijer-Sevink; Patricia van Oppen; Harold J van Megen; Neeltje M Batelaan; Danielle C Cath; Nic J A van der Wee; Marcel A van den Hout; Anton J van Balkom
Journal:  J Affect Disord       Date:  2013-04-15       Impact factor: 4.839

8.  Twenty-five-year course and outcome in anxiety and depression in the Upper Bavarian Longitudinal Community Study.

Authors:  M M Fichter; N Quadflieg; U C Fischer; G Kohlboeck
Journal:  Acta Psychiatr Scand       Date:  2009-11-18       Impact factor: 6.392

9.  Recurrence of anxiety disorders and its predictors.

Authors:  Willemijn D Scholten; Neeltje M Batelaan; Anton Jlm van Balkom; Brenda Wjh Penninx; Johannes H Smit; Patricia van Oppen
Journal:  J Affect Disord       Date:  2012-12-04       Impact factor: 4.839

10.  Psychological treatment of obsessive-compulsive disorder in patients with major depression: a pilot randomized controlled trial.

Authors:  Neil A Rector; Stephanie E Cassin; Margaret A Richter
Journal:  Can J Psychiatry       Date:  2009-12       Impact factor: 4.356

View more
  1 in total

1.  The effect of cyberchondria on anxiety, depression and quality of life during COVID-19: the mediational role of obsessive-compulsive symptoms and Internet addiction.

Authors:  Federica Ambrosini; Roberto Truzoli; Matteo Vismara; Daniele Vitella; Roberta Biolcati
Journal:  Heliyon       Date:  2022-05-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.